206 related articles for article (PubMed ID: 8719364)
1. Orthotopic bladder substitutes: histopathologic risk factors.
Nabeeh A; Gomha M; Shaaban AA; el-Baz M; el-Dosoky I; Ashamallah A; Ghoneim MA
Scand J Urol Nephrol; 1995 Dec; 29(4):463-7. PubMed ID: 8719364
[TBL] [Abstract][Full Text] [Related]
2. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
3. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
Huguet J
Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder.
Nixon RG; Chang SS; Lafleur BJ; Smith JA JA; Cookson MS
J Urol; 2002 Feb; 167(2 Pt 1):502-5. PubMed ID: 11792906
[TBL] [Abstract][Full Text] [Related]
5. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
[TBL] [Abstract][Full Text] [Related]
6. Urethral recurrence in patients following orthotopic urinary diversion.
Hassan JM; Cookson MS; Smith JA; Chang SS
J Urol; 2004 Oct; 172(4 Pt 1):1338-41. PubMed ID: 15371836
[TBL] [Abstract][Full Text] [Related]
7. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Albers P; Heidenreich A
Aktuelle Urol; 2014 Nov; 45(6):490-8. PubMed ID: 25514780
[No Abstract] [Full Text] [Related]
9. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
10. Positive Pre-cystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder Substitution.
Roth B; Furrer MA; Giannakis I; Vartolomei MD; Boxler S; Wuethrich PY; Burkhard FC; Thalmann GN; Kiss B
J Urol; 2019 May; 201(5):909-915. PubMed ID: 30694935
[TBL] [Abstract][Full Text] [Related]
11. [Urethral recurrence after cysto-prostatectomy for bladder tumor].
Robert M; Burgel JS; Serre I; Guiter J; Grasset D
Prog Urol; 1996; 6(4):558-63. PubMed ID: 8924933
[TBL] [Abstract][Full Text] [Related]
12. Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy.
Lebret T; Hervé JM; Barré P; Gaudez F; Lugagne PM; Barbagelatta M; Botto H
Eur Urol; 1998; 33(2):170-4. PubMed ID: 9519359
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.
Wood DP; Montie JE; Pontes JE; VanderBrug Medendorp S; Levin HS
J Urol; 1989 Feb; 141(2):346-9. PubMed ID: 2913357
[TBL] [Abstract][Full Text] [Related]
14. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
15. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.
Revelo MP; Cookson MS; Chang SS; Shook MF; Smith JA; Shappell SB
J Urol; 2004 Feb; 171(2 Pt 1):646-51. PubMed ID: 14713778
[TBL] [Abstract][Full Text] [Related]
16. Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens.
Mahadevia PS; Koss LG; Tar IJ
Cancer; 1986 Nov; 58(9):2096-102. PubMed ID: 3530431
[TBL] [Abstract][Full Text] [Related]
17. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.
Abbas F; Hochberg D; Civantos F; Soloway M
Eur Urol; 1996; 30(3):322-6. PubMed ID: 8931964
[TBL] [Abstract][Full Text] [Related]
18. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
[TBL] [Abstract][Full Text] [Related]
19. Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?
Iselin CE; Robertson CN; Webster GD; Vieweg J; Paulson DF
J Urol; 1997 Dec; 158(6):2123-6. PubMed ID: 9366327
[TBL] [Abstract][Full Text] [Related]
20. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
